WHO Backs Ebola Vaccine Trial

KinshasaNo licensed vaccine protects against Bundibugyo virus.

The outbreak has already become the second-largest Ebola epidemic ever recorded.

Animal studies suggest the existing vaccine Ervebo may cross-protect, prompting WHO to recommend a Phase III trial.

The Democratic Republic of Congo has confirmed 4,449 cases and 2,061 deaths across five provinces.